Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma.
about
Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatmentsLiver resection for intermediate hepatocellular carcinomaLaparoscopic liver resection for hepatocellular carcinoma in patients with cirrhosisTreatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive reviewStrategies to increase the resectability of hepatocellular carcinomaManagement of hepatocellular carcinoma with portal vein thrombosisTranscatheter embolization therapy in liver cancer: an update of clinical evidencesSystematic review of catheter-based intra-arterial therapies in hepatocellular carcinoma: state of the art and future directionsRecommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?Surgery and Hepatocellular CarcinomaControversies and evidence of hepatic resection for hepatocellular carcinomaLiver transplantation for hepatocellular carcinoma from living-donor vs. deceased donorUpdate in management of hepatocellular carcinoma in Eastern populationHepatocellular carcinoma: A comprehensive reviewDevelopment and Validation of a New Prognostic System for Patients with Hepatocellular CarcinomaComparison of hepatocellular carcinoma in Eastern versus Western populations.Diffusion-Weighted Imaging with Two Different b-Values in Detection of Solid Focal Liver Lesions.Tumor stage and primary treatment of hepatocellular carcinoma at a large tertiary hospital in China: A real-world study.Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohortBarcelona clinic liver cancer-stage C hepatocellular carcinoma: A novel approach to subclassification and treatment.Advanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization.Barcelona Clinic Liver Cancer outperforms Hong Kong Liver Cancer staging of hepatocellular carcinoma in multiethnic Asians: Real-world perspective.International validation of the Chinese university prognostic index for staging of hepatocellular carcinoma: a joint United Kingdom and Hong Kong studyMinimally invasive local therapies for liver cancerComparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinomaIdentifying Staging Markers for Hepatocellular Carcinoma before Transarterial Chemoembolization: Comparison of Three-dimensional Quantitative versus Non-three-dimensional Imaging MarkersHong Kong consensus recommendations on the management of hepatocellular carcinoma.Management of Hepatocellular Carcinoma: Current Status and Future Directions.Subclassification of patients with solitary hepatocellular carcinoma based on post-hepatectomy survival: a large retrospective study.The ITA.LI.CA Staging System: A Novel Staging System for Hepatocellular Carcinoma.Solitary Large Hepatocellular Carcinoma: Staging and Treatment StrategyNeutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: A systematic review and meta-analysis of observational studiesA comparison of clinical manifestations and prognoses between patients with hepatocellular carcinoma and Child-Pugh scores of 5 or 6.Hepatocellular Carcinoma Patients With Performance Status 1 Deserve New Classification and Treatment Algorithm in the BCLC System.Hong Kong Liver Cancer Staging System Is Associated With Better Performance for Hepatocellular Carcinoma: Special Emphasis on Viral EtiologyValidation of a Modified Child-Turcotte-Pugh Classification System Utilizing Insulin-Like Growth Factor-1 for Patients with Hepatocellular Carcinoma in an HBV Endemic Area.Treatment algorithm based on the multivariate survival analyses in patients with advanced hepatocellular carcinoma treated with trans-arterial chemoembolizationYttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma.Fucoidan protects hepatocytes from apoptosis and inhibits invasion of hepatocellular carcinoma by up-regulating p42/44 MAPK-dependent NDRG-1/CAP43.Hepatic resection provided long-term survival for patients with intermediate and advanced-stage resectable hepatocellular carcinoma.
P2860
Q26743666-E8339011-2F89-454E-8356-ACBF81D548ECQ26748756-3D1C9006-8DC9-4B74-93D8-81D71687D4C1Q26770500-2720354F-587E-4A28-83EB-A0357C72702EQ26772299-269F63DA-5D71-495D-8BEE-57532DCC8097Q26795530-0B147414-1DCC-4EF3-AEF7-0333A6C16590Q26996578-2C4E2605-680D-416B-81FE-91F7594C83FFQ27003849-76AB4914-CB44-4E96-BCE6-E15400264F2DQ27007847-F0553B37-EEC9-43AC-BFBF-C09E30494948Q27022015-FB6146F0-B6B3-42BC-9B95-4D3328F5048FQ28072274-A6B0B041-DF92-4C65-AEB2-C9416BBE7645Q28072742-524CF1B8-D51E-4583-AA49-FE76D00497D5Q28073940-DD497AC1-888A-4406-8A5C-1D890CC53851Q28080480-CE0F458E-680D-4D28-BBD8-29606E6B8F6CQ28087638-95D7A629-516D-4809-A891-8A7793D73513Q28551586-CDA5D25D-50D2-4C3D-B4C0-E2AC2282B01DQ30245396-73AFDDAC-2072-4018-9C5C-3A55E75888DCQ30387548-DE1A6394-ACDD-4E01-9504-965A72EA9789Q33566921-AF6054ED-EDC0-438D-822B-DB604636E6AEQ33572657-DA57A2C6-9232-4D5B-BC56-7203398E6B10Q33627217-14964AEC-35C1-4422-986B-2E15192B7FE6Q33797067-1F501B03-D78D-4BF6-87B5-6608ACDCF535Q33805894-C80CFA43-BD68-4042-8CB7-D43AED48DA99Q34346779-AEEDF6D1-6E95-4A39-BA60-9E73E949C83BQ34974386-BC3CBC55-89FE-4C56-9A13-7F676CD196A9Q35473069-AFA8D59E-D7FE-432B-92FB-8DEFF74BA7F7Q35537007-7C0D54D2-9185-4600-A91D-FA549DB95382Q35631295-9B48BF0C-7E59-41EC-BCB1-8E4A52C53A0BQ35771842-B761B0A3-47C7-4F54-81B8-C406BB4783B6Q35839618-BDDE8980-5831-4492-A2D9-2B638EA3486EQ35999601-6A32BD0E-CC62-4672-898D-806C8093C5A6Q36016881-619C34AC-61C6-469F-A51A-D52688DAEB0BQ36052780-F1CAC79B-DE9F-4E8C-B7EA-8410F074589EQ36151682-80AF3B8F-0CD7-41C8-B513-8686AF899823Q36153539-0B1D2A1A-5C67-44E7-B1FF-7803C674CB54Q36195552-EDDBBD26-8A37-4318-8814-6E97FA5C0465Q36255571-E9763320-4066-4D59-9152-24F3131B50B9Q36272834-98237945-131A-422B-BA36-2C6B62C6D932Q36326015-473EC35D-96D3-49C3-B0C4-7E8BB99D3D6EQ36363383-18A967DD-604C-4DF6-978F-EAB485D6B2E4Q36646019-E92BD9B8-DE28-453B-AFBA-EE4D4C53CF23
P2860
Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Development of Hong Kong Liver ...... with hepatocellular carcinoma.
@en
Development of Hong Kong Liver ...... with hepatocellular carcinoma.
@nl
type
label
Development of Hong Kong Liver ...... with hepatocellular carcinoma.
@en
Development of Hong Kong Liver ...... with hepatocellular carcinoma.
@nl
prefLabel
Development of Hong Kong Liver ...... with hepatocellular carcinoma.
@en
Development of Hong Kong Liver ...... with hepatocellular carcinoma.
@nl
P2093
P1433
P1476
Development of Hong Kong Liver ...... with hepatocellular carcinoma
@en
P2093
Chung-Mau Lo
Ronnie T P Poon
Sheung-Tat Fan
Tzy-Jyun Yao
Vikki Y F Tang
P304
1691-700.e3
P356
10.1053/J.GASTRO.2014.02.032
P407
P50
P577
2014-02-25T00:00:00Z